BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Neutec Group Launches oCelloscope: Automated Microbial Live-Cell Imaging by Biosense Solutions

With +80 US/EU peer reviewed publications, the oCelloScope is a one-of-a-kind workhorse in many microbial applications. In AST,...

May 17, 2023 | News

Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy Development

Lonza launches the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamlin...

May 16, 2023 | News

Cytiva and Pall Life Sciences merge to form a comprehensive solutions provider for biotechnology challenges, with focus on innovation and digitalization

Discover how the combined technical expertise, talent, and portfolio offerings of these two distinguished brands are driving the next generation of medicin...

May 12, 2023 | News

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

Sonelokimab is MoonLake Immunotherapeutics' investigational anti-IL-17 A/F Nanobody technology designed to more directly target sites of inflammation and p...

May 11, 2023 | News

Thermo Fisher & Pfizer team up to bring cancer testing to global markets

Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access t...

May 10, 2023 | News

Novavax's COVID-Influenza Combo and High-dose COVID Vaccine Show Strong Immune Responses in Phase 2

This Phase 2 trial is evaluating three vaccine candidates: COVID-Influenza Combination, stand-alone influenza and high-dose COVID Preliminary topline im...

May 10, 2023 | News

PerkinElmer Unveils Revvity, its Innovative Science-Based Solutions Company for Life Sciences and Diagnostics

Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...

May 09, 2023 | News

Biosion shares Anti-CD40 Agonistic Antibody discovery and development data at PEGS

BSI-038 is an anti-CD40 agonistic monoclonal antibody, discovered through Biosion's H³ antibody discovery platform. BSI-038 exhibits enhanced bin...

May 09, 2023 | News

Ascletis approved for Phase IIa clinical trial of ASC10 for RSV infection in China

--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Do...

May 09, 2023 | News

Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform

Nous-209 has been developed using the Nouscom's viral vector platform, which includes adenoviral and Modified Vaccinia Ankara (MVA) vectors, with MVA vecto...

May 04, 2023 | News

Clinisys Acquires Promium to Further Grow Scientific, Environmental and Public Health Diagnostics Capabilities

Clinisys announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated...

May 04, 2023 | News

Agilent Introduces 8697 Headspace Sampler XL Tray for Smart GC Systems

This new Agilent 8697 -XL Tray also includes the latest instrument intelligence features for increased uptime and operator ease-of-use compared to it...

May 04, 2023 | News

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy i...

May 04, 2023 | News

Revolutionizing Drug Development: IQVIA's David Cameron on the Power of Innovative Trial Designs

Can you tell us about your role as Senior Director & Global Head of Novel Trial Design at IQVIA? The Novel Trial Design initiative at IQ...

May 09, 2023 | News

Stay Connected